MENU
+Compare
PFE
Stock ticker: NYSE
AS OF
Feb 3 closing price
Price
$25.77
Change
+$0.53 (+2.10%)
Capitalization
151.58B

PFE Pfizer Forecast, Technical & Fundamental Analysis

Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion... Show more

PFE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for PFE with price predictions
Feb 02, 2026

PFE in +2.15% Uptrend, rising for three consecutive days on February 02, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where PFE advanced for three days, in of 286 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 02, 2026. You may want to consider a long position or call options on PFE as a result. In of 77 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for PFE just turned positive on January 08, 2026. Looking at past instances where PFE's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

PFE moved above its 50-day moving average on January 14, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for PFE crossed bullishly above the 50-day moving average on January 08, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 20 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 222 cases where PFE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for PFE moved out of overbought territory on January 28, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 similar instances where the indicator moved out of overbought territory. In of the 36 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PFE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

PFE broke above its upper Bollinger Band on January 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. PFE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.633) is normal, around the industry mean (9.533). P/E Ratio (15.500) is within average values for comparable stocks, (24.433). PFE's Projected Growth (PEG Ratio) (13.773) is very high in comparison to the industry average of (1.907). PFE's Dividend Yield (0.064) is considerably higher than the industry average of (0.025). P/S Ratio (2.424) is also within normal values, averaging (3.990).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PFE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock worse than average.

View a ticker or compare two or three
PFE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

PFE is expected to report earnings to fall 14.91% to 74 cents per share on May 05

Pfizer PFE Stock Earnings Reports
Q1'26
Est.
$0.74
Q3'25
Beat
by $0.21
Q2'25
Beat
by $0.21
Q1'25
Beat
by $0.24
Q4'24
Beat
by $0.15
The last earnings report on November 04 showed earnings per share of 87 cents, beating the estimate of 66 cents. With 41.73M shares outstanding, the current market capitalization sits at 151.58B.
A.I.Advisor
published Dividends

PFE is expected to pay dividends on March 06, 2026

Pfizer PFE Stock Dividends
A dividend of $0.43 per share will be paid with a record date of March 06, 2026, and an ex-dividend date of January 23, 2026. The last dividend of $0.43 was paid on December 01. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of vaccines and injectable biologic medicines

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
66 Hudson Boulevard East
Phone
+1 212 733-2323
Employees
88000
Web
https://www.pfizer.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
XLI167.532.09
+1.26%
State Street® IndstrlSelSectSPDR®ETF
PFM53.240.49
+0.94%
Invesco Dividend Achievers™ ETF
JUNP30.800.06
+0.18%
PGIM S&P 500 Buffer 12 ETF - Jun
GDMA41.57-0.24
-0.57%
Gadsden Dynamic Multi-Asset ETF
XNAV85.48-2.27
-2.58%
FundX Aggressive ETF

PFE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PFE has been closely correlated with BMY. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if PFE jumps, then BMY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PFE
1D Price
Change %
PFE100%
+0.83%
BMY - PFE
67%
Closely correlated
+1.53%
BIIB - PFE
67%
Closely correlated
-0.44%
AMGN - PFE
63%
Loosely correlated
+0.82%
NVS - PFE
58%
Loosely correlated
+1.59%
ABBV - PFE
58%
Loosely correlated
+1.18%
More

Groups containing PFE

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PFE
1D Price
Change %
PFE100%
+0.83%
PFE
(4 stocks)
81%
Closely correlated
-0.63%